In silico mutagenesis: a case study of the melanocortin 4 receptor.

TitleIn silico mutagenesis: a case study of the melanocortin 4 receptor.
Publication TypeJournal Article
Year of Publication2009
AuthorsBromberg, Y, Overton, J, Vaisse, C, Leibel, RL, Rost, B
JournalFASEB J
Volume23
Issue9
Pagination3059-69
Date Published2009 Sep
ISSN1530-6860
KeywordsAmino Acid Sequence, Animals, Computer Simulation, Humans, Mice, Mutagenesis, Point Mutation, Receptor, Melanocortin, Type 4, Receptors, G-Protein-Coupled
Abstract

The melanocortin 4 receptor (MC4R) is a G-protein-coupled receptor (GPCR) and a key molecule in the regulation of energy homeostasis. At least 159 substitutions in the coding region of human MC4R (hMC4R) have been described experimentally; over 80 of those occur naturally, and many have been implicated in obesity. However, assessment of the presumably functionally essential residues remains incomplete. Here we have performed a complete in silico mutagenesis analysis to assess the functional essentiality of all possible nonnative point mutants in the entire hMC4R protein (332 residues). We applied SNAP, which is a method for quantifying functional consequences of single amino acid (AA) substitutions, to calculate the effects of all possible substitutions at each position in the hMC4R AA sequence. We compiled a mutability score that reflects the degree to which a particular residue is likely to be functionally important. We performed the same experiment for a paralogue human melanocortin receptor (hMC1R) and a mouse orthologue (mMC4R) in order to compare computational evaluations of highly related sequences. Three results are most salient: 1) our predictions largely agree with the available experimental annotations; 2) this analysis identified several AAs that are likely to be functionally critical, but have not yet been studied experimentally; and 3) the differential analysis of the receptors implicates a number of residues as specifically important to MC4Rs vs. other GPCRs, such as hMC1R.

DOI10.1096/fj.08-127530
Alternate JournalFASEB J.
PubMed ID19417090
PubMed Central IDPMC2735358
Grant ListR01 DK052431-17 / DK / NIDDK NIH HHS / United States
R01 DK052431-18 / DK / NIDDK NIH HHS / United States
R01 DK052431-19 / DK / NIDDK NIH HHS / United States
R01 DK060540 / DK / NIDDK NIH HHS / United States
R01-DK068152 / DK / NIDDK NIH HHS / United States
R01-DK52431-15 / DK / NIDDK NIH HHS / United States
R01-DK60540 / DK / NIDDK NIH HHS / United States
R01-LM07329-01 / LM / NLM NIH HHS / United States